Madala Samantha, Davuluru Shaili, Li Joy, Gluckstein Jeffrey, Martin John, Khatibi Kasra, Zhang-Nunes Sandy
University of Southern California (USC) Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA, United States.
Independent Practitioner, Coral Gables, FL, United States.
Front Ophthalmol (Lausanne). 2025 Apr 11;5:1568370. doi: 10.3389/fopht.2025.1568370. eCollection 2025.
Injectable cosmetic fillers have dramatically risen in popularity in recent years. However, as the use of such fillers has become more common, there have been many reports of vision loss secondary to misplaced filler embolizing to the ophthalmic artery resulting in ocular ischemia. Currently, there are no randomized control trials or widely validated clinical guidelines that dictate how injectors should manage ischemic complications of filler embolism. This review aims to explain the possible mechanisms by which a cosmetic filler embolus can occlude the ophthalmic artery, describe the types of treatments that have been attempted thus far, and delineate possible a stroke-like protocol that can be implemented in order to restore perfusion and recover vision after such ischemic complications have occurred.
近年来,可注射美容填充剂的受欢迎程度急剧上升。然而,随着此类填充剂的使用变得更加普遍,有许多关于视力丧失的报道,这些视力丧失继发于填充剂误置并栓塞至眼动脉,导致眼部缺血。目前,尚无随机对照试验或广泛验证的临床指南来指导注射者应如何处理填充剂栓塞的缺血性并发症。本综述旨在解释美容填充剂栓子可能阻塞眼动脉的机制,描述迄今为止尝试过的治疗类型,并阐述在发生此类缺血性并发症后为恢复灌注和恢复视力而可实施的类似中风的方案。